Maze Therapeutics Inc (NASDAQ:MAZE)’s traded shares stood at 78157.0 during the last session. At the close of trading, the stock’s price was $11.5, to imply a decrease of -3.04% or -$0.36 in intraday trading. The MAZE share’s 52-week high remains $17.00, putting it -47.83% down since that peak but still an impressive 41.65% since price per share fell to its 52-week low of $6.71. The company has a valuation of $503.66M, with an average of 0.13 million shares in intraday trading volume over the past 10 days and average of 153.18K shares over the past 3 months.
Maze Therapeutics Inc (NASDAQ:MAZE) trade information
After registering a -3.04% downside in the last session, Maze Therapeutics Inc (MAZE) has traded red over the past five days. The 5-day price performance for the stock is -9.73%, and -15.81% over 30 days. Short interest in Maze Therapeutics Inc (NASDAQ:MAZE) saw shorts transact 2.15 million shares and set a 23.84 days time to cover.
MAZE Dividends
Maze Therapeutics Inc has its next earnings report out on 2025-May-14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Maze Therapeutics Inc (NASDAQ:MAZE)’s Major holders
Maze Therapeutics Inc insiders hold 5.91% of total outstanding shares, with institutional holders owning 92.17% of the shares at 97.95% float percentage. In total, 92.17% institutions holds shares in the company.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and AB CAP FUND, INC.-AB Small Cap Growth Portfolio as the top two Mutual Funds with the largest holdings of the Maze Therapeutics Inc (MAZE) shares. Going by data provided on Mar 31, 2025, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 464.88 shares. This is just over 1.06% of the total shares, with a market valuation of $5.35 million. Data from the same date shows that the other fund manager holds a little less at 283.58, or 0.65% of the shares, all valued at about 3.26 million.
